DOCSLIB.ORG

Immunoassay Platforms and Products: R&D Systems

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Immunoassay Platforms and Products: R&D Systems IMMUNOASSAY WORKFLOW SOLUTIONS ANTIBODY ARRAYS, LUMINEX® ASSAYS, ELISAS & SIMPLE PLEX™ ASSAYS TABLE OF CONTENTS Which Immunoassay is Right For You? ..................................................................................3 What’s New ........................................................................................................................... 4-5 Immunoassay Options from Discovery to Validation ...........................................................6 Move Between Immunoassay Platforms with Confidence .................................................7 Immunoassay Offering by Molecule ...............................................................................8-36 Luminex High Performance Fixed Panels ......................................................................37-38 Luminex High Performance Assays ................................................................................39-40 Proteome Profiler Antibody Arrays ................................................................................41-51 2 WHICH IMMUNOASSAY IS RIGHT FOR YOU? NUMBER OF SAMPLE KIT FORMAT BENEFIT ASSAY TIME INSTRUMENT ANALYTES VOLUME Most Quantikine ELISA 1 96-well plate Published 10-200mL 3-5 Hours Plate Reader Low CVs Simplified protocol Quantikine QuicKit 1 96-well plate 50mL 1.5 Hours Plate Reader Results in 90 mins Quantikine HS Highest 1 96-well plate 10-200mL 4-4.5 Hours Plate Reader ELISA Sensitivity Economical DuoSet ELISAs 1 Flexible Largest Menu 100mL 20 Hours Plate Reader Flexible Hands Free Simple Plex Assays Up to 8 Cartridge 2.5-25mL 1.5 Hours ELLA Sensitive Completely Luminex High Up to 45 Bead-based Optimized 25mL 4 Hours Luminex Performance Assays Panels Luminex Discovery Most Flexible Up to 50 Bead-based 25mL 4 Hours Luminex Assays Panels Largest Proteome Profiler Membrane Imaging Up to 119 Screening 50-500mL 20 Hours Arrays Array System Capabilities Learn more | rndsystems.com/immunoassays 3 WHAT’S NEW? LUMINEX LEARNING LUMINEX ASSAY USERS LUMINEX HIGH ACADEMY GUIDE PERFORMANCE PANELS FOR IMMUNE PROFILING The MagPix® Luminex® Download to Learn: Learning Plan at the • Human XL Cytokine Bio-Techne Academy has • What is a Luminex assay 45-plex Fixed Panel – LKTM014 all the training you need to • Which Luminex assay is right get up and running on your for you • Human XL Cytokine MagPix® Instrument. The Configurable Panel – course includes modules • How to ensure performance FCSTM18 on Luminex technology, and consistency • Human Th1/Th2 installation, ordering and • Multiplex assay best practices 11-plex Fixed Panel – running R&D Systems® and techniques LKTM008 assays, working in xPonent, maintenance protocols • And More! • Human Th9/Th17/Th22 17-plex Fixed Panel – and troubleshooting. LKTM009 So, whether you need a refresher, have a new • Human Immunotherapy colleague that needs 24-plex Fixed Panel – LKTM010 training, or need to get certified to use MagPix, the • NHP XL Cytokine Bio-Techne Academy is the Configurable Panel – place to learn. Self-register FCSTM21 at Academy.Bio-techne.com. 4 PROTEIN A ELISA INTERFERON GAMMA FAST & REPRODUCIBLE COVID-SEROINDEX KIT FOR ANTIBODY ELISAS HOST CELL PROTEIN KANTARO MANUFACTURING DETECTION IN THE QUANTITATIVE SARS- Interferon Gamma BIOPROCESSING COV-2 IGG ANTIBODY (IFN-gamma) is central to During antibody WORKFLOW RUO KIT POWERED BY manufacturing, Protein A many cellular and immune R&D SYSTEMS or its fragments may leach processes. Accurate Chinese Hamster Ovary from a purification column quantification of this cell (CHO) host cell The COVID-SeroIndex and remain bound to the cytokine is crucial in a proteins (HCPs) are a is a quantitative IgG Fc region of a therapeutic variety of workflows source of contamination antibody enzyme-linked antibody. The Protein A ranging from basic during the production of immunosorbent assay ELISA kit is for the detection immunology research to recombinant therapeutic (ELISA) kit that enables an of natural and recombinant cell therapy manufacturing. proteins or biologics. objective measurement of Protein A constructs while Learn more about all of Business and regulatory SARS-CoV-2 IgG antibodies the Protein A Engineered Bio-Techne’s IFN-gamma standards require accurate which is indicative of prior Variant ELISA kit detects immunoassays. quantification of CHO infection. This 2-phase unnatural recombinant HCPs in all in-process ELISA is accurate, proven, • Human IFN-gamma Protein A constructs. samples during the and accessible. Quantikine ELISA Learn more about Protein bioprocess workflow. Learn more about the Kit – DIF50C A ELISAs. Download the application COVID-SeroIndex ELISA. • Human IFN-gamma note to learn how Cygnus • Protein A ELISA • COVID-SeroIndex Quantikine HS ELISA Technologies CHO HCP Kit – BPPA00 ELISA – DSR200 Kit – HSDIF0 3G-1 antibodies pair with • Protein A ELISA Kit for Simple Plex assays on Ella Engineered Variant – for fast and reproducible BPPAEV0 HCP detection. • Learn about Simple Plex Assays and Ella • CHO HCP 3G-1 Simple Plex Assay 5 IMMUNOASSAY OPTIONS FROM DISCOVERY TO VALIDATION MULTIPLEX ASSAYS DISCOVERY VALIDATION Proteome ProfilerTM Luminex® Luminex® High Simple PlexTM Arrays Discovery Assays Performance Assays Multiplex Cartidges • Analyze up to 119 • Customized panels. • Rigorously validated for • Automated detection proteins simultaneously. accuracy, precision, and of up to 8 analytes. • Quantify up to 50 reproducibility. • Quickly assess complex analytes simultaneously. • High throughput. signaling responses. • Flexible panels available. SINGLE ANALYTE ASSAYS DISCOVERY VALIDATION RESULTS Duosets® Development ELISAs Quantikine® ELISAs Simple PlexTM Single or Multianalyte Cartridges • Economical and adaptable to • Exhaustively validated for superior • Hands-Free. Data in 90 minutes. multiple platforms. performance and reproducibility. • Multiple formats available. • Over 1,000 kits available covering • The most referenced ELISAs in 16 species. literature. 6 MOVE BETWEEN IMMUNOASSAY RELIABLE PLATFORMS WITH CONFIDENCE BIO-TECHNE IS YOUR IMMUNOASSAY PARTNER. REPRODUCIBLE POWERED BY R&D SYSTEMS We offer a full catalog of immunoassay solutions so you can find the best platform for your needs. When your needs CONSISTENT MOST PUBLISHED change, you can also move between platforms with confidence CUSTOMIZABLE and consistency in your results. High Performance Luminex QUALITY ROBUST Assays and Simple Plex Cartridges are both correlated to the ACCURATE gold standard Quantikine ELISA. Whether you are starting with a multiplex assay or single analyte, we have your current and future needs covered. A. B. QUALITY AT THE CORE • Core Reagents – R&D Systems antibodies, proteins, and specialized diluents are the foundation of all our immunoassays. High quality raw materials are essential for building accurate and reproducible assays. • Expertise – Bio-Techne brands have over 35 years of C. experience developing and manufacturing immunoassays. Our expertise is used to build the most reliable assays with superior accuracy and precision. • Accuracy – Specialized diluents are used to overcome effects seen by complex sample matrices, so you get the most accurate and trusted results. • Quality Control – Every raw material and complete kit goes through stringent quality control testing to make sure your assays remain consistent over time and your data is reproducible. • Custom Services – Customized immunoassay solutions including modification of an existing assay, species testing Serum IFN-gamma detection is highly correlated across Bio-Techne’s immunoassay and qualification, and new immunoassay development are platforms. A. The Quantikine HS ELISA is highly correlated with Simple Plex Assay (R2=0.997). B. Similarly, HS ELISA data is also highly correlated with Luminex assay available to fit your experimental needs. data (R2=0.97). C. Finally, data collection using the Simple Plex Assay is highly correlated with Luminex Assay (R2=0.98). 7 IMMUNOASSAY OFFERING BY MOLECULE PROTEOME LUMINEX LUMINEX HIGH DUOSET QUANTIKINE SIMPLE MOLECULE PROFILER DISCOVERY PERFORMANCE UNCOATED COATED PLEX ARRAYS ASSAYS ASSAYS ELISAS ELISAS ASSAYS 14-3-3 zeta H 20S Immunoproteasome H 25-OH Vitamin D 4-1BB/TNFRSF9/CD137 H H M ACE/CD143 H H M H Acetylcholinesterase/ACHE H Activin A H H H M R ADAM10 H ADAM12 H H ADAM15 H H ADAM8 H H ADAM9 H H ADAMTS1 H H ADAMTS13 H H H H ADAMTS4 H ADAMTS5 H Adiponectin/Acrp30 H M R H M H H M R H M R Afamin H Aggrecan H H Agrin R AgRP/ART M H H H Akt, Phospho (S473) Pan Specific H H M R Akt1 H M R Akt1, Phospho (S473) H M Akt2 Akt3 Albumin H ALCAM/CD166 H H H M Aldehyde Dehydrogenase 1-A1/ALDH1A1 H Aldosterone MS ALK-1 H alpha 1-Acid Glycoprotein H H alpha 1B-Glycoprotein H alpha 1-Microglobulin H alpha 2-Macroglobulin H H KEY: Human H, Mouse M, Rat R, Canine C, Primate Pr, Porcine P, Multi-Species MS, Viral V, Bovine B, C. botulinum Cb, Cotton Rabbit CR, Equine E, Guinea Pig G, Rabbit Rb, *In Development Learn more | rndsystems.com/immunoassays 8 IMMUNOASSAY OFFERING BY MOLECULE PROTEOME LUMINEX LUMINEX HIGH DUOSET QUANTIKINE SIMPLE MOLECULE PROFILER DISCOVERY PERFORMANCE UNCOATED COATED PLEX ARRAYS ASSAYS ASSAYS ELISAS ELISAS ASSAYS alpha-Defensin 1 H alpha-Fetoprotein/AFP H H H M H M H alpha-N-acetylglucosaminidase/NAGLU H alpha-Synuclein H H AMICA/JAML H Aminoacylase/ACY1 H Aminopeptidase N/CD13 H H Amphiregulin H M H M H H AMPK alpha 1 H H M R AMPK alpha 1, Phospho (T183) H Amyloid beta H Amyloid beta aa 1-42 H Angiogenin H H H H H Angiopoietin-1 H M H H H H Angiopoietin-2 H M H M H H M R H M R Angiopoietin-3
Load more

Recommended publications
  • Development and Maintenance of Epidermal Stem Cells in Skin Adnexa
    International Journal of Molecular Sciences Review Development and Maintenance of Epidermal Stem Cells in Skin Adnexa Jaroslav Mokry * and Rishikaysh Pisal Medical Faculty, Charles University, 500 03 Hradec Kralove, Czech Republic; [email protected] * Correspondence: [email protected] Received: 30 October 2020; Accepted: 18 December 2020; Published: 20 December 2020 Abstract: The skin surface is modified by numerous appendages. These structures arise from epithelial stem cells (SCs) through the induction of epidermal placodes as a result of local signalling interplay with mesenchymal cells based on the Wnt–(Dkk4)–Eda–Shh cascade. Slight modifications of the cascade, with the participation of antagonistic signalling, decide whether multipotent epidermal SCs develop in interfollicular epidermis, scales, hair/feather follicles, nails or skin glands. This review describes the roles of epidermal SCs in the development of skin adnexa and interfollicular epidermis, as well as their maintenance. Each skin structure arises from distinct pools of epidermal SCs that are harboured in specific but different niches that control SC behaviour. Such relationships explain differences in marker and gene expression patterns between particular SC subsets. The activity of well-compartmentalized epidermal SCs is orchestrated with that of other skin cells not only along the hair cycle but also in the course of skin regeneration following injury. This review highlights several membrane markers, cytoplasmic proteins and transcription factors associated with epidermal SCs. Keywords: stem cell; epidermal placode; skin adnexa; signalling; hair pigmentation; markers; keratins 1. Epidermal Stem Cells as Units of Development 1.1. Development of the Epidermis and Placode Formation The embryonic skin at very early stages of development is covered by a surface ectoderm that is a precursor to the epidermis and its multiple derivatives.
    [Show full text]
  • Overexpresssion of Tyrosine Kinase Discoidin Domain Receptor I (DDR1 ) in Transitional Cell Carcinoma
    Overexpresssion of Tyrosine Kinase Discoidin domain receptor I (DDR1 ) in Transitional cell Carcinoma Szu-Ting Chen,* and Shie-Liang Hsieh* Institute and Department of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan; To whom proofs are to be sent: Shie-Liang Hsieh, Department and Institute of Microbiology and Immunology, National Yang-Ming University, Shih-Pai, Taipei 112, Taiwan. E-mail address: [email protected] Telephone number: 886-2-28267161 Fax number: 886-2-28277933 INTRODUCTION DDR1, discoidin domain receptor 1, belongs to the novel subfamily of tyrosine kinase receptor, which forms homodimer upon ligand engagement. DDR1 is distinguished from other receptor tyrosine kinase by the discoidin domain in their extracellular domain, which is a homology region originally identified in Dictyostelium discoideum (slime mold) protein, discoidin I, and involves in cells aggregation. Discoidin-1 has binding specificity toward galactose and N-acetyl galactosamine and is essential for slime mold cells adhesion, migration and aggregation during its development, suggesting that DDR1 shared similar biologically function in mammalian [1-3]. DDR1 has been found mainly distributed and in human tissue epithelia, such as kidney, breast, lung [3], bronchial [4] and keratinocytes [5]. Furthermore, DDR1 has been also reported its expression in immune system like the monocyte-derived dendritic cells, annotated as CD167 [6] and macrophage[7]. However, recently, the overexpression of DDR1 has been detected in several human cancers, such as primary breast cancer [1, 8, 9] ovarian[10, 11], brain[12], esophageal cancer [13], and TCC (our data unpublished) in which raising the possibility that DDR1 may play a important role in tumorigenesis [14].
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Tools for Cell Therapy and Immunoregulation
    RnDSy-lu-2945 Tools for Cell Therapy and Immunoregulation Target Cell TIM-4 SLAM/CD150 BTNL8 PD-L2/B7-DC B7-H1/PD-L1 (Human) Unknown PD-1 B7-1/CD80 TIM-1 SLAM/CD150 Receptor TIM Family SLAM Family Butyrophilins B7/CD28 Families T Cell Multiple Co-Signaling Molecules Co-stimulatory Co-inhibitory Ig Superfamily Regulate T Cell Activation Target Cell T Cell Target Cell T Cell B7-1/CD80 B7-H1/PD-L1 T cell activation requires two signals: 1) recognition of the antigenic peptide/ B7-1/CD80 B7-2/CD86 CTLA-4 major histocompatibility complex (MHC) by the T cell receptor (TCR) and 2) CD28 antigen-independent co-stimulation induced by interactions between B7-2/CD86 B7-H1/PD-L1 B7-1/CD80 co-signaling molecules expressed on target cells, such as antigen-presenting PD-L2/B7-DC PD-1 ICOS cells (APCs), and their T cell-expressed receptors. Engagement of the TCR in B7-H2/ICOS L 2Ig B7-H3 (Mouse) the absence of this second co-stimulatory signal typically results in T cell B7-H1/PD-L1 B7/CD28 Families 4Ig B7-H3 (Human) anergy or apoptosis. In addition, T cell activation can be negatively regulated Unknown Receptors by co-inhibitory molecules present on APCs. Therefore, integration of the 2Ig B7-H3 Unknown B7-H4 (Mouse) Receptors signals transduced by co-stimulatory and co-inhibitory molecules following TCR B7-H5 4Ig B7-H3 engagement directs the outcome and magnitude of a T cell response Unknown Ligand (Human) B7-H5 including the enhancement or suppression of T cell proliferation, B7-H7 Unknown Receptor differentiation, and/or cytokine secretion.
    [Show full text]
  • Human ADAM12 Quantikine ELISA
    Quantikine® ELISA Human ADAM12 Immunoassay Catalog Number DAD120 For the quantitative determination of A Disintegrin And Metalloproteinase domain- containing protein 12 (ADAM12) concentrations in cell culture supernates, serum, plasma, and urine. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures. TABLE OF CONTENTS SECTION PAGE INTRODUCTION .....................................................................................................................................................................1 PRINCIPLE OF THE ASSAY ...................................................................................................................................................2 LIMITATIONS OF THE PROCEDURE .................................................................................................................................2 TECHNICAL HINTS .................................................................................................................................................................2 MATERIALS PROVIDED & STORAGE CONDITIONS ...................................................................................................3 OTHER SUPPLIES REQUIRED .............................................................................................................................................3 PRECAUTIONS .........................................................................................................................................................................4
    [Show full text]
  • Quantikine® ELISA
    Quantikine® ELISA Human ADAMTS13 Immunoassay Catalog Number DADT130 For the quantitative determination of human A Disintegrin And Metalloproteinase with Thombospondin type 1 motif, 13 (ADAMTS13) concentrations in cell culture supernates, serum, and plasma. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures. TABLE OF CONTENTS SECTION PAGE INTRODUCTION .....................................................................................................................................................................1 PRINCIPLE OF THE ASSAY ...................................................................................................................................................2 LIMITATIONS OF THE PROCEDURE .................................................................................................................................2 TECHNICAL HINTS .................................................................................................................................................................2 MATERIALS PROVIDED & STORAGE CONDITIONS ...................................................................................................3 OTHER SUPPLIES REQUIRED .............................................................................................................................................4 PRECAUTIONS .........................................................................................................................................................................4
    [Show full text]
  • ALCAM Regulates Mediolateral Retinotopic Mapping in the Superior Colliculus
    15630 • The Journal of Neuroscience, December 16, 2009 • 29(50):15630–15641 Development/Plasticity/Repair ALCAM Regulates Mediolateral Retinotopic Mapping in the Superior Colliculus Mona Buhusi,1 Galina P. Demyanenko,1 Karry M. Jannie,2 Jasbir Dalal,1 Eli P. B. Darnell,1 Joshua A. Weiner,2 and Patricia F. Maness1 1Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, and 2Department of Biology, University of Iowa, Iowa City, Iowa 52242 ALCAM [activated leukocyte cell adhesion molecule (BEN/SC-1/DM-GRASP)] is a transmembrane recognition molecule of the Ig superfamily (IgSF) containing five Ig domains (two V-type, three C2-type). Although broadly expressed in the nervous and immune systems, few of its developmental functions have been elucidated. Because ALCAM has been suggested to interact with the IgSF adhesion molecule L1, a determi- nant of retinocollicular mapping, we hypothesized that ALCAM might direct topographic targeting to the superior colliculus (SC) by serving as a substrate within the SC for L1 on incoming retinal ganglion cell (RGC) axons. ALCAM was expressed in the SC during RGC axon targeting and on RGC axons as they formed the optic nerve; however, it was downregulated distally on RGC axons as they entered the SC. Axon tracing with DiI revealedpronouncedmistargetingofRGCaxonsfromthetemporalretinahalfofALCAMnullmicetoabnormallylateralsitesinthecontralateral SC, in which these axons formed multiple ectopic termination zones. ALCAM null mutant axons were
    [Show full text]
  • Eradication of ENO1-Deleted Glioblastoma Through Collateral Lethality
    bioRxiv preprint doi: https://doi.org/10.1101/331538; this version posted May 25, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Eradication of ENO1-deleted Glioblastoma through Collateral Lethality Yu-Hsi Lin1, Nikunj Satani1,2, Naima Hammoudi1, Jeffrey J. Ackroyd1, Sunada Khadka1, Victoria C. Yan1, Dimitra K. Georgiou1, Yuting Sun3, Rafal Zielinski4, Theresa Tran1, Susana Castro Pando1, Xiaobo Wang1, David Maxwell5, Zhenghong Peng6, Federica Pisaneschi1, Pijus Mandal7, Paul G. Leonard8, Quanyu Xu,9 Qi Wu9, Yongying Jiang9, Barbara Czako10, Zhijun Kang10, John M. Asara11, Waldemar Priebe4, William Bornmann12, Joseph R. Marszalek3, Ronald A. DePinho13 and Florian L. Muller#1 1) Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 2) Institute of Stroke and Cerebrovascular Disease, The University of Texas Health Science Center at Houston, TX 77030 3) Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 4) Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 5) Institutional Analytics & Informatics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 6) Cardtronics, Inc., Houston, TX 77042 7) Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 bioRxiv preprint doi: https://doi.org/10.1101/331538; this version posted May 25, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Negatively Regulated by ADAM15 TRIF-Mediated TLR3 and TLR4
    TRIF-Mediated TLR3 and TLR4 Signaling Is Negatively Regulated by ADAM15 Suaad Ahmed, Ashwini Maratha, Aisha Qasim Butt, Enda Shevlin and Sinead M. Miggin This information is current as of September 27, 2021. J Immunol 2013; 190:2217-2228; Prepublished online 30 January 2013; doi: 10.4049/jimmunol.1201630 http://www.jimmunol.org/content/190/5/2217 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/01/30/jimmunol.120163 Material 0.DC1 References This article cites 57 articles, 20 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/190/5/2217.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology TRIF-Mediated TLR3 and TLR4 Signaling Is Negatively Regulated by ADAM15 Suaad Ahmed, Ashwini Maratha, Aisha Qasim Butt, Enda Shevlin, and Sinead M.
    [Show full text]
  • Flow Reagents Single Color Antibodies CD Chart
    CD CHART CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 gene product, E2 p p p CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (γ-glutamyl transferase) p p p p p p CD1c R7, M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n l CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n l CD228 Melanotransferrin (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n
    [Show full text]
  • Decorin, a Growth Hormone-Regulated Protein in Humans
    178:2 N Bahl and others Growth hormone increases 178:2 145–152 Clinical Study decorin Decorin, a growth hormone-regulated protein in humans Neha Bahl1,2, Glenn Stone3, Mark McLean2, Ken K Y Ho1,4 and Vita Birzniece1,2,5 1Garvan Institute of Medical Research, Sydney, New South Wales, Australia, 2School of Medicine, Western Sydney Correspondence University, Blacktown Clinical School and Research Centre, Blacktown Hospital, Blacktown, New South Wales, should be addressed Australia, 3School of Computing, Engineering and Mathematics, Western Sydney University, Penrith, New South to V Birzniece Wales, Australia, 4Centres of Health Research, Princess Alexandra Hospital, Brisbane, Queensland, Australia, and Email 5School of Medicine, University of New South Wales, New South Wales, Australia v.birzniece@westernsydney. edu.au Abstract Context: Growth hormone (GH) stimulates connective tissue and muscle growth, an effect that is potentiated by testosterone. Decorin, a myokine and a connective tissue protein, stimulates connective tissue accretion and muscle hypertrophy. Whether GH and testosterone regulate decorin in humans is not known. Objective: To determine whether decorin is stimulated by GH and testosterone. Design: Randomized, placebo-controlled, double-blind study. Participants and Intervention: 96 recreationally trained athletes (63 men, 33 women) received 8 weeks of treatment followed by a 6-week washout period. Men received placebo, GH (2 mg/day), testosterone (250 mg/week) or combination. Women received either placebo or GH (2 mg/day). Main outcome measure: Serum decorin concentration. Results: GH treatment significantly increased mean serum decorin concentration by 12.7 ± 4.2%; P < 0.01. There was a gender difference in the decorin response to GH, with greater increase in men than in women (∆ 16.5 ± 5.3%; P < 0.05 compared to ∆ 9.4 ± 6.5%; P = 0.16).
    [Show full text]
  • Conservation and Divergence of ADAM Family Proteins in the Xenopus Genome
    Wei et al. BMC Evolutionary Biology 2010, 10:211 http://www.biomedcentral.com/1471-2148/10/211 RESEARCH ARTICLE Open Access ConservationResearch article and divergence of ADAM family proteins in the Xenopus genome Shuo Wei*1, Charles A Whittaker2, Guofeng Xu1, Lance C Bridges1,3, Anoop Shah1, Judith M White1 and Douglas W DeSimone1 Abstract Background: Members of the disintegrin metalloproteinase (ADAM) family play important roles in cellular and developmental processes through their functions as proteases and/or binding partners for other proteins. The amphibian Xenopus has long been used as a model for early vertebrate development, but genome-wide analyses for large gene families were not possible until the recent completion of the X. tropicalis genome sequence and the availability of large scale expression sequence tag (EST) databases. In this study we carried out a systematic analysis of the X. tropicalis genome and uncovered several interesting features of ADAM genes in this species. Results: Based on the X. tropicalis genome sequence and EST databases, we identified Xenopus orthologues of mammalian ADAMs and obtained full-length cDNA clones for these genes. The deduced protein sequences, synteny and exon-intron boundaries are conserved between most human and X. tropicalis orthologues. The alternative splicing patterns of certain Xenopus ADAM genes, such as adams 22 and 28, are similar to those of their mammalian orthologues. However, we were unable to identify an orthologue for ADAM7 or 8. The Xenopus orthologue of ADAM15, an active metalloproteinase in mammals, does not contain the conserved zinc-binding motif and is hence considered proteolytically inactive. We also found evidence for gain of ADAM genes in Xenopus as compared to other species.
    [Show full text]